Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
Recruiting · NCT07136285 · Registry updated 2025-12-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC | SCLC, Extensive Stage | Recruiting | Phase 1 / Phase 2 | 2025-12-03 | NCT07136285 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genelux Corporation | 3 |
| Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Chest Hospital | Shanghai | China | 56 |
| Zhejiang Provincial People's Hospital | Hangzhou | China | 19 |